Mankind Pharma Limited
MANKIND.NS

$12.1 B
Marketcap
$30.20
Share price
Country
$-0.08
Change (1 day)
$34.01
Year High
$21.55
Year Low

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.

marketcap

P/E ratio for Mankind Pharma Limited (MANKIND.NS)

P/E ratio as of 2023: 48.41

According to Mankind Pharma Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 48.41. At the end of 2022 the company had a P/E ratio of 44.45.

P/E ratio history for Mankind Pharma Limited from 2018 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 48.41
2022 44.45
2021 39.75
2020 45.02
2019 55.29
2018 98.50